FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

769516003: Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3695465018 Rotigotine 83.333 microgram/hour prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
3695466017 Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has basis of strength substance Rotigotine true Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Is a Product containing rotigotine in transdermal dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator unit hour true Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has manufactured dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength numerator value 83.333 false Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has precise active ingredient Rotigotine true Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Has concentration strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Is a Product containing only rotigotine in transdermal dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start